{"id":"https://genegraph.clinicalgenome.org/r/12a06644-a8d1-47fb-a028-3adb782ba0adv1.0","type":"EvidenceStrengthAssertion","dc:description":"*HBB* was first reported in relation to autosomal dominant unstable hemoglobin disease in 1962 (Frick et al. 1962, PMID: 13895148). Unstable hemoglobin disease results from the presence of a structurally abnormal hemoglobin variant which leads to Heinz bodies or basophilic inclusions in the red blood cells. The disease is characterized by hemolytic anemia, heat-labile hemoglobin, and is sometimes accompanied by splenomegaly and jaundice. The clinical severity and presentation of the unstable hemoglobinopathies vary widely. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanisms, inheritance pattern, and phenotypic variability in unstable hemoglobin disease and other disease entities associated with *HBB*. Therefore, the following disease entities have been split into multiple disease entities: AD familial erythrocytosis 7, AD and AR alpha-thalassemia, AD hemoglobin M disease, AD unstable hemoglobin disease, and AR Sickle cell disease. This curation addresses *HBB* in relation to AD unstable hemoglobin disease. At least 14 unique missense variants that have been reported in 15 probands in 14 publications (PMIDs: 13895148, 6771953, 6877904, 3781864, 8330973, 9730372, 11920235, 29573049, 25347256, 20730880, 30032685, 32029504, 33613322, 37457725) are included in this curation. Eight were reported as de novo occurrences. This gene disease association is also supported by experimental evidence including expression pattern of HBB across human tissues which is highly specific within whole blood (PMID: 23715323), biochemical studies indicating the well-established function of *HBB* in oxygen binding (PMID: 11747442), and its protein-protein interaction with the alpha hemoglobin chain encoded by *HBA1* and *HBA2* genes (PMID: 6644819), which harbors variants associated with unstable hemoglobin disease. Additionally, an ENU-induced mouse model replicated the human phenotype (PMIDs: 28304246). In summary, there is definitive evidence supporting the relationship between *HBB* and autosomal dominant unstable hemoglobin disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen General Gene Curation Expert Panel on 2/28/2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/12a06644-a8d1-47fb-a028-3adb782ba0ad","GCISnapshot":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10026","date":"2024-12-09T11:07:02.528Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10026","date":"2024-02-28T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64aed39f-3bd7-413f-8486-9560a725d7f4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64aed39f-3bd7-413f-8486-9560a725d7f4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Extremely high affinity for oxygen, heat, isopropanol,  and mechanical stability showed the variant to be more unstable than Hb A and Hb S (PMID: 3839771)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/64aed39f-3bd7-413f-8486-9560a725d7f4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20730880","allele":{"id":"https://genegraph.clinicalgenome.org/r/91fd82c8-7eab-4917-8201-a447071f0bce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.266T>C (p.Leu89Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125149"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/63f000d9-d281-40be-904d-663a35ac7344","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63f000d9-d281-40be-904d-663a35ac7344_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Heat stability and isopropanol tests showed positive results\n(PMID: 6175783)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/63f000d9-d281-40be-904d-663a35ac7344_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/13895148","allele":{"id":"https://genegraph.clinicalgenome.org/r/ee187355-284c-464a-a89d-c5dac918beb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.191A>G (p.His64Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125255"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2b7713e8-f439-4239-bc5e-34b39739dd36","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b7713e8-f439-4239-bc5e-34b39739dd36_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"heat stability and n-butanol tests showed positive results indicating instability of the variant\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2b7713e8-f439-4239-bc5e-34b39739dd36_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9730372","allele":{"id":"https://genegraph.clinicalgenome.org/r/f933cfa8-c2f0-477c-a5df-aba23eeea51a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.415G>C (p.Ala139Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA124766"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7925f43b-9b3e-4d9a-b7cc-76fd7b292902","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7925f43b-9b3e-4d9a-b7cc-76fd7b292902_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Heat stability and isopropanol tests showed positive results indicating instability of the variant\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7925f43b-9b3e-4d9a-b7cc-76fd7b292902_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37457725","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c65f34b-5cdf-4447-ada1-36d080639da0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.202G>A (p.Val68Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA124768"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5fd0ec3d-28eb-42b7-8b2b-71a11aad2e5f","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5fd0ec3d-28eb-42b7-8b2b-71a11aad2e5f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Isopropanol stability test showed significant flocculent precipitation indicating instability of the variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5fd0ec3d-28eb-42b7-8b2b-71a11aad2e5f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30032685","allele":{"id":"https://genegraph.clinicalgenome.org/r/612796eb-caff-4efa-a6e5-b4d7f186d861","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.127T>A (p.Phe43Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379274528"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0b93f255-f6d5-4836-ba9a-cd434222ae73","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b93f255-f6d5-4836-ba9a-cd434222ae73_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive heat stability test indicating variant is unstable\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0b93f255-f6d5-4836-ba9a-cd434222ae73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25347256","allele":{"id":"https://genegraph.clinicalgenome.org/r/707d6391-5f59-4530-89ce-cf24aaeeb37a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.305A>C (p.Glu102Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA217113460"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/31369105-c225-4a51-82e3-cb504c05e9d8","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31369105-c225-4a51-82e3-cb504c05e9d8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Heat stability test and isopropanol test were positive indicating instability of the variant\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/31369105-c225-4a51-82e3-cb504c05e9d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8330973","allele":{"id":"https://genegraph.clinicalgenome.org/r/77863b96-f1e7-4037-a4d4-ac2a05aa52d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.83C>A (p.Ala28Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125229"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2ab6cb68-3d3a-4c94-be72-fbc4ca776ee5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ab6cb68-3d3a-4c94-be72-fbc4ca776ee5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive heat stability test indicating instability of the variant (PMID: 25572187)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2ab6cb68-3d3a-4c94-be72-fbc4ca776ee5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20730880","allele":{"id":"https://genegraph.clinicalgenome.org/r/02745e77-248a-42f1-8b30-888e9a840514","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.206T>C (p.Leu69Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125036"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ee2913c6-bf4d-4132-9b56-ca2ffcdd998e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee2913c6-bf4d-4132-9b56-ca2ffcdd998e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Both isopropanol and heat stability tests were indicative of instability\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ee2913c6-bf4d-4132-9b56-ca2ffcdd998e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6771953","allele":{"id":"https://genegraph.clinicalgenome.org/r/da89d444-0576-4d09-840b-be29fba2e8de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.86T>C (p.Leu29Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA124877"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6f0c391c-f42e-4ee9-8ce2-f87f9a1f79b2","type":"EvidenceLine","dc:description":"Given that they did not do stability assays on these, we can’t really say that they would fit with the definition of unstable hemoglobin disease.  ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f0c391c-f42e-4ee9-8ce2-f87f9a1f79b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33613322","allele":{"id":"https://genegraph.clinicalgenome.org/r/7760d0ae-c188-412b-94e1-4ae4ca2454ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.442T>A (p.Ter148Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379273639"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3351da53-4988-4470-b09d-5d4205dd6054","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3351da53-4988-4470-b09d-5d4205dd6054_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32029504","allele":{"id":"https://genegraph.clinicalgenome.org/r/71eb8567-3430-4ca0-a323-a5742e4995d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.391T>G (p.Tyr131Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125233"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a17f1a9a-443a-424d-b951-c836caec1d52","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a17f1a9a-443a-424d-b951-c836caec1d52_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive isopropanol test indicating the variant is unstable\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a17f1a9a-443a-424d-b951-c836caec1d52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29573049","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc294f42-47d3-4b5f-b540-dffe4dd5a2b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.212C>A (p.Ala71Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125154"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3daa7cd7-2e36-41d2-a722-97c60b3f159f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3daa7cd7-2e36-41d2-a722-97c60b3f159f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Heat and isopropanol tests were positive showing instability of the variant\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3daa7cd7-2e36-41d2-a722-97c60b3f159f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6877904","allele":{"id":"https://genegraph.clinicalgenome.org/r/345ac03e-7743-4f73-bc76-50ffaa295816","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.137T>C (p.Phe46Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA124791"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dae1cfd6-b00f-4772-9dfe-a11fd6fdf9f1","type":"EvidenceLine","dc:description":"Given that they did not do stability assays on these, we can’t really say that they would fit with the definition of unstable hemoglobin disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dae1cfd6-b00f-4772-9dfe-a11fd6fdf9f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33613322","allele":{"id":"https://genegraph.clinicalgenome.org/r/1509335f-8ecd-424a-bf0a-70aeb897c7ad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.442T>C (p.Ter148Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379273638"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/24e2ae0d-69ac-46d7-8698-29b3691555a4","type":"EvidenceLine","dc:description":"Not scored due to the diagnostic uncertainty between spherocytosis and unstable hemoglobinopathy","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24e2ae0d-69ac-46d7-8698-29b3691555a4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive stability tests indicated instability of the variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/24e2ae0d-69ac-46d7-8698-29b3691555a4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33613322","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fcfd96a-ad44-44cc-a2db-002487b78006","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.290T>C (p.Leu97Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125432"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ab418cb8-9bd3-4dbc-b6bc-a3199a5b33e1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab418cb8-9bd3-4dbc-b6bc-a3199a5b33e1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive heat stability and isopropanol tests, oxygen dissociation curves demonstrate a lower oxygen anity and a decreased heme-heme interaction\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ab418cb8-9bd3-4dbc-b6bc-a3199a5b33e1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11920235","allele":{"id":"https://genegraph.clinicalgenome.org/r/46325512-223b-4623-91aa-1f32006c28c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.129T>G (p.Phe43Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379274522"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5061ccc5-11c9-474f-b7e7-e0c33fda07fb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5061ccc5-11c9-474f-b7e7-e0c33fda07fb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive heat and isopropanol tests (numerous Heinz bodies), oxygen equilibrium studies showed lowered oxygen affinity\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5061ccc5-11c9-474f-b7e7-e0c33fda07fb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3781864","allele":{"id":"https://genegraph.clinicalgenome.org/r/adb973e1-8ffd-4fe5-8803-d0c15fdcfad6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000518.5(HBB):c.127T>G (p.Phe43Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA125156"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/615cbbbf-7363-48aa-8314-21ec01566a53","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/615cbbbf-7363-48aa-8314-21ec01566a53_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Positive stability tests indicating instability of the variant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/615cbbbf-7363-48aa-8314-21ec01566a53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33613322","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c65f34b-5cdf-4447-ada1-36d080639da0"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.1},{"id":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79e70043-14d8-4509-9f3b-ddec9a51a684","type":"EvidenceLine","dc:description":"Upgraded by the GCEP as this is an ENU model that fully recapitulates the human disease with a variant that was observed in human cases","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/765c3482-fb89-42be-b1c3-bcfa0c048d99","type":"Finding","dc:description":"Introduction of Hb Santa Ana (c.266T>C (p.Leu89Pro)), a rare unstable hemoglobin described in humans (PMID: 7928381, 20730880), replicated the phenotypes of unstable hemoglobin with hemolytic anemia and Heinz body formation. Affected Anem/+ mice were paler and smaller than their normal littermates at birth. Hematologic evaluation of Anem/+ mice revealed phenotypes characteristic of a congenital hemolytic regenerative anemia, similar to human anemias due to unstable hemoglobin. They had moderate anemia with intense reticulocytosis and polychromasia, anisocytosis, macrocytosis, hypochromia, intraerythrocytic inclusion and Heinz bodies, hemoglobinuria, bilirubinemia, and erythrocytic populations with differing resistance to osmotic lysis. Splenomegaly was observed particularly in older mutant mice and jaundice was also seen. Histopathologic examination revealed dramatically increased hematopoiesis and hemosiderosis in hematopoietic organs and intracellular iron deposition in tubular renal cells.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28304246","rdfs:label":"ENU induced mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/814a7d4b-c79b-4f68-9873-0d8477ee95a2_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f535a9c-bd3f-4774-a904-b2e59c654b2e","type":"EvidenceLine","dc:description":"Upgraded by the GCEP as this biochemical function is well-established in the HBA1/HBA2 literature.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84dff3c7-6328-46a2-98cc-afd3c80f34fd","type":"Finding","dc:description":"The protein product of HBA1/HBA2 is part of a complex that functions to bind oxygen and release oxygen. The article shows the function of HBA1/HBA2 as a component of an oxygen-carrying complex (hemoglobin) that is central to the ability of red blood cells to oxygenate the body.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11747442","rdfs:label":"Kidd biochemical function ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/92ef0f9e-0850-48b9-95b2-b6eb539db3f0","type":"EvidenceLine","dc:description":"Upgraded as this evidence provides a link to genes associated with unstable hemoglobinopathy","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8555d1c3-550e-4966-aca9-649a25415b5e","type":"Finding","dc:description":"The human HBB protein has been co-crystallized with the product of the HBA1 gene (identical to that of the HBA2 gene) in the form of a multimeric complex (oxyhemoglobin). Variants in HBA1 and HBA2 have been associated with unstable hemoglobinopathy","dc:source":"https://pubmed.ncbi.nlm.nih.gov/6644819","rdfs:label":"Protein interaction with HBA1/2","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/88da73f5-272f-45de-9f71-b6e3d42a1e88","type":"EvidenceLine","dc:description":"Upgraded by the GCEP due to the high specificity of HBB expression within whole blood, which is consistent with hematological phenotypes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e7ce724-1cb2-475f-a169-68d9380563d4","type":"Finding","dc:description":"RNA-seq profiling of HBB expression across more than 50 human tissues identified highly specific expression in whole blood","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"Expression in whole blood","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":9473,"specifiedBy":"GeneValidityCriteria10","strengthScore":16.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/lxBE0BfHueA","type":"GeneValidityProposition","disease":"obo:MONDO_0020459","gene":"hgnc:4827","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_814a7d4b-c79b-4f68-9873-0d8477ee95a2-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}